A next-generation anticancer drug developed by Academia Sinica researchers could greatly boost the life expectancy of people suffering from colorectal cancer and increase the chances of curing the disease, a scientist said yesterday.
Academia Sinica research fellow Wu Han-chung (吳漢忠) said that his research team has developed an anti-cancer drug that is significantly more efficient than existing ones by conjugating peptides — protein segments — with liposomes.
He said that traditional chemotherapeutic drugs consist of fine particles and spread to other parts to the body, impeding the functions of normal cells and causing serious side effects.
Due to the high pressure in tumor sites, caused by ruptures innate to the blood vessels in tumors, it is very difficult for anti-cancer drugs to penetrate tumors, Wu added.
He said that by embedding the right peptides in the surface of liposomes, which measure 100 nanometers and are small enough to seep into openings in the tumor blood vessels, the researchers found that two anti-cancer drugs, Doxorubicin and Vinorelbine, which they encapsulated in the liposomes, were effectively delivered to tumor cells.
Since peptides are highly tumor-specific and have an outstanding binding affinity with cancer cells, they help the liposomal drug to locate tumors, Wu said.
The lipid membrane is then dissolved by the acidic environment in tumor sites, releasing Doxorubicin and Vinorelbin, he said.
The team used a contrast medium to highlight the areas showing Doxorubicin accumulation in tumors implanted in mice, and found that drug accumulation increased by 10 to 15 times over existing therapies using only liposome, while the accumulation of chemotherapeutic drugs was so low that no highlighted areas were shown.
Test results from six mice indicated that after administering the liposomal drug for 30 days, tumors implanted in three test subjects shrank significantly, while those in the other three were completely eliminated.
On average, the tumors implanted in the mice shrank by 98 percent.
All test mice survived a 120-day duration — about equivalent to 10 years in a human’s lifespan — suggesting that the newly created drug could mean a 100 percent survival rate in humans, the researchers said.
Wu said that most chemotherapeutic drugs extend a patient’s life expectancy by only about six months at best.
Furthermore, he said that a test using the peptides identified by his team, conducted among 78 colorectal cancer patients, found that the peptides successfully targeted tumor cells in 80 percent of the patients.
Furthermore, the results showed that the peptides can target even stage-one colorectal cancer cells, which could greatly help doctors diagnose cancer at an early stage, boosting survival rates, he said.
He said that the project targeted colorectal cancer because it has been the most common cancer in Taiwan over the past seven years, but the therapy is showing good prospects of treating other types of cancer.
“The liposomal drug is like a guided missile for tumors,” said Wu Chien-hsun (吳建勳) the research’s first author.
The team’s research was published in the Science Translational Medicine journal on Wednesday.
Taiwan is to receive the first batch of Lockheed Martin F-16 Block 70 jets from the US late this month, a defense official said yesterday, after a year-long delay due to a logjam in US arms deliveries. Completing the NT$247.2 billion (US$7.69 billion) arms deal for 66 jets would make Taiwan the third nation in the world to receive factory-fresh advanced fighter jets of the same make and model, following Bahrain and Slovakia, the official said on condition of anonymity. F-16 Block 70/72 are newly manufactured F-16 jets built by Lockheed Martin to the standards of the F-16V upgrade package. Republic of China
Taiwan-Japan Travel Passes are available for use on public transit networks in the two countries, Taoyuan Metro Corp said yesterday, adding that discounts of up to 7 percent are available. Taoyuan Metro, the Taipei MRT and Japan’s Keisei Electric Railway teamed up to develop the pass. Taoyuan Metro operates the Taiwan Taoyuan International Airport MRT Line, while Keisei Electric Railway offers express services between Tokyo’s Narita Airport, and the Keisei Ueno and Nippori stations in the Japanese capital, as well as between Narita and Haneda airports. The basic package comprises one one-way ticket on the Taoyuan MRT Line and one Skyliner ticket on
A new tropical storm formed late yesterday near Guam and is to approach closest to Taiwan on Thursday, the Central Weather Administration (CWA) said. Tropical Storm Pulasan became the 14th named storm of the year at 9:25pm yesterday, the agency said. As of 8am today, it was near Guam traveling northwest at 21kph, it said. The storm’s structure is relatively loose and conditions for strengthening are limited, WeatherRisk analyst Wu Sheng-yu (吳聖宇) said on Facebook. Its path is likely to be similar to Typhoon Bebinca, which passed north of Taiwan over Japan’s Ryukyu Islands and made landfall in Shanghai this morning, he said. However, it
Starlux Airlines, Taiwan’s newest international carrier, has announced it would apply to join the Oneworld global airline alliance before the end of next year. In an investor conference on Monday, Starlux Airlines chief executive officer Glenn Chai (翟健華) said joining the alliance would help it access Taiwan. Chai said that if accepted, Starlux would work with other airlines in the alliance on flight schedules, passenger transits and frequent flyer programs. The Oneworld alliance has 13 members, including American Airlines, British Airways, Cathay Pacific and Qantas, and serves more than 900 destinations in 170 territories. Joining Oneworld would also help boost